Nexamedic proudly reflects on its participation at Dreiländertagung 2025, a key vascular medicine congress connecting experts from Switzerland, Germany and Austria. The event provided valuable discussions on clinical challenges, evolving endovascular techniques and the importance of reliable medical-device distribution. These exchanges reinforced nexamedic’s commitment to long-term partnerships and high-quality support for hospitals. With inspiring sessions, demonstrations and networking, the congress reaffirmed the power of collaboration in driving innovation and improving patient outcomes across the vascular community.
The nexamedic booth at DLT 2025 was a busy place, with clients, prospects, friends and colleagues all dropping by.
Dreiländertagung is the flagship trination vascular-disease congress. Held in Lucerne in 2025, it brought together physicians, researchers, clinicians and industry partners from across the D-A-CH region for four days of scientific sessions, live demonstrations and networking opportunities. This congress stands out because it blends cutting-edge clinical insight with hands-on learning. As a distributor deeply involved in the vascular field, the event offers exactly what we value most: staying close to evolving clinical needs, understanding technological shifts and engaging directly with the professionals shaping patient care.
Nexamedic was founded by three experienced medtech professionals who wanted to rethink how medical devices reach hospitals in Switzerland. We don’t see ourselves as simple wholesalers — we place ourselves within the entire value chain, from understanding product development to managing distribution logistics and providing clinical support when needed. Our goal is simple: to make a meaningful difference in the distribution of impactful medical devices in Switzerland. We carefully curate our product portfolio so every device we promote offers clear, proven clinical value. Our customers benefit from:
A few of the medical devices that nexamedic distributes in Switzerland.
During the event, we had the opportunity to:
Our time at Dreiländertagung confirmed several principles that guide our work:
We’re proud to have played an active role at Dreiländertagung 2025. Our thanks go to the organizers, speakers, partners and everyone who visited our stand, shared insights or simply stopped by to connect. For us, the congress wasn’t just another industry gathering — it reaffirmed our purpose. We look forward to continuing these conversations, strengthening relationships, and expanding our role in medical device distribution across Switzerland. Together with our partners and the wider vascular community, we remain committed to advancing vascular care with precision, consistency and a long-term vision. Because for us — and for the clinicians we serve — it’s the long game that drives real progress.